See more funds from Threadneedle Inv Services Ltd
See more funds in the UK Equity & Bond Income sector
See more funds managed by: Richard Colwell
Threadneedle Managed Income 2 Fund Inc
Fund Overview |
|
|---|---|
| Unit Prices |
Buy: 57.81p
/ Sell: 57.81p
24/05/2012 |
| Standard Initial Charge | n/a |
| TQ Invest Discount | 0.00% |
| Initial Charge Through TQ Invest | n/a |
| Annual Management Charge | 1.34% |
| Total Expense Ratio | 1.52% |
| Fund size | £92,700,000 |
| Usable in ISA | No |
Fund holding information
| Holding | Weighting |
|---|---|
| Glaxosmithkline | 4.20% |
| Royal Dutch Shell | 3.00% |
| Bt Group | 2.60% |
| Imperial Tobacco Group | 2.40% |
| Astrazeneca Plc | 2.40% |
| Rsa Insurance Group Plc | 2.30% |
| Unilever | 2.20% |
| British American Tobacco | 2.00% |
| Legal & General Group | 1.90% |
| Bae Systems | 1.50% |
| Sector | Weighting |
|---|
| Region | Weighting |
|---|---|
| Uk | 76.60% |
| International | 11.60% |
| Europe Ex Uk | 10.90% |
| Money Market | 0.90% |
| Asset Type | Weighting |
|---|---|
| Uk Equities | 58.30% |
| Uk Fixed Interest | 18.30% |
| International Equities | 11.60% |
| European Equities | 10.90% |
| Money Market | 0.90% |
Data provided by 
The value of this investment and the income from it can go down as well as up. Past performance should not be regarded as a guide to the future. The investment described may not be suitable for all recipients and this factsheet does not constitute personalised investment advice. No liability is accepted for any loss arising from errors or omissions.